ACC 2006

Sirolimus Eluting Stent Superior in Meta Analysis

Antonio Abbate
Antonio Abbate, Medical College of Virginia, Richmond
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 2912-74
Even though drug eluting stents have gained greatly in popularity for coronary intervention, hard evidence about the relative merits of paclitaxel as compared with sirolimus-eluting devices has been thin on the ground. At the ACC conference a meta analyis combined data from 5000 patients and showed superiority in terms of binary rates of restenosis (but not hard clinical endpoints) for the sirolumus eluting stent. Peter Goodwin heard the details from Antonio Abatte.

Similar Interviews

  • Primary Angioplasty: Sirolimus Eluting Stent Cuts MACE Rates In Half
  • Christian Spaulding, Rene Descartes University American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta Primary PCI is even more effective

  • Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty">Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty
  • CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New

  • ENDEAVOR or Cypher? Comparison of Drug Eluting Stents
  • The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University's David Kandzari told us more. [audio:http://www.audiomedica.com/podcasting/aha2005/David_Kandzari.mp3]Click here for

    Post a comment

    Subscribe to Audio Medica Podcast